Agilent Announces USC Collaboration
Agilent Technologies has announced a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience with the aim of creating an Agilent Center of Excellence (CoE) in biomolecular characterization.
Agilent Technologies (Santa Clara, California, USA) has announced a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience with the aim of creating an Agilent Center of Excellence (CoE) in biomolecular characterization.
“Agilent’s collaboration with the Michelson Center is an excellent example of how academia and industry can work together, sharing knowledge and expertise to shorten the timeline between scientific discoveries and real-world applications,” said Darlene Solomon, senior vice president and chief technology officer for Agilent.
The center will bring researchers together from across science and engineering to work together on multidisciplinary approaches, aiming to develop improved health care through new drugs, diagnostics, and medical devices.
Key to the Agilent CoE will be a collaboration with the USC Michelson Center principal investigator Valery Fokin. The Fokin laboratory at USC focuses on chemical reactivity and biological interactions at the molecular level and will contribute to multiple collaborative drug discovery projects ranging from chemical synthesis of screening and focused libraries and biological assay implementation to the development of targeted drug delivery systems, diagnostics, and vaccines.
Additional notable contributors to this collaboration include: Steve Kay, Provost Professor of Neurology, Biomedical Engineering, and Biological Sciences; Raymond C. Stevens, Provost Professor of Biological Sciences and Chemistry; and Peter Kuhn, Dean’s Professor of Biological Sciences.
“Convergent bioscience research requires successful collaboration across multiple disciplines-a holistic approach that is central to Agilent’s view of the future,” said Solomon.
For more information, please visit www.agilent.com or https://michelson.usc.edu/
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
